Adjuvant testosterone therapy in chronic heart failure (ATTIC): a randomised open-label trial

INTRODUCTION: Heart failure is a major contributor to morbidity and mortality in the geriatric population, with no promising therapy currently available with considerable benefit. Testosterone therapy is an emerging viable treatment option given its beneficial effects, including improving cardiac fu...

Descripción completa

Detalles Bibliográficos
Autores principales: Dhar, Minakshi, Mittal, Kartik, Parchani, Ashwin, Sharma, Manu, Bahurupi, Yogesh, Kalra, Sanjay, Bhat, Nowneet Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2022
Materias:
Geriatric Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157332/
https://www.ncbi.nlm.nih.gov/pubmed/35641010
http://dx.doi.org/10.1136/bmjopen-2021-056994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9157332/
https://www.ncbi.nlm.nih.gov/pubmed/35641010
http://dx.doi.org/10.1136/bmjopen-2021-056994

Ejemplares similares